AMARIN CORP PLC\UK Accrued Liabilities and Other Liabilities
AMARIN CORP PLC\UK (AMRN) had Accrued Liabilities and Other Liabilities of $73.75 million as of 2018-06-30, per its 10-Q filed 2018-08-01.
Discontinued › Notes
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2018-08-01
- 2018-06-30: Accrued Liabilities and Other Liabilities $73.75M.
- 2018-03-31: Accrued Liabilities and Other Liabilities $61.31M.
- 2017-12-31: Accrued Liabilities and Other Liabilities $58.90M.
- 2017-09-30: Accrued Liabilities and Other Liabilities $51.63M.
| Period end | Accrued Liabilities and Other Liabilities |
|---|---|
| 2018-06-30 | $73.75M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $61.31M 10-Q · filed 2018-05-02 |
| 2017-12-31 | $58.90M 10-Q · filed 2018-08-01 |
| 2017-09-30 | $51.63M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $49.10M 10-Q · filed 2017-08-02 |
| 2017-03-31 | $44.43M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $37.72M 10-K · filed 2018-02-27 |
| 2016-09-30 | $38.33M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $31.05M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $24.55M 10-Q · filed 2016-05-05 |
| 2015-12-31 | $24.23M 10-K · filed 2017-03-01 |
| 2014-12-31 | $16.39M 10-K · filed 2016-02-25 |
| 2013-09-30 | $12.55M 10-Q · filed 2013-11-07 |
| 2013-06-30 | $14.36M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $11.94M 10-Q · filed 2013-05-09 |
| 2012-12-31 | $5.22M 10-Q · filed 2013-11-07 |
| 2011-12-31 | $4.03M 10-K · filed 2013-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |